You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
「中醫股」固生堂(02273.HK)回升逾6% 中金升價至62元料受惠鼓勵生育國策
阿思達克 02-09 15:44
本港首隻連鎖「中醫股」固生堂(02273.HK)扭上日跌勢,今日(9日)走高,最高見54.75元。現報54.05元,回升6.6%,成交85.84萬股,涉資4,568.87萬元。 中金髮表報告,指國家醫保局近日對政協委員提案的答覆函中,明確提到要鼓勵中醫醫院開設優生優育門診,提供不孕不育診療服務;同時加強婦幼中醫藥人才隊伍建設,鼓勵西醫婦產科臨牀醫師學習中醫等。政策引導中醫婦科加速發展,有望打造新增長點。 報告指,疫情限制因素減弱,期待固生堂今年可觀業績韌性。後疫情時代,線上線下齊發力,加速業務擴張。維持對其2022至2023盈利預測及「跑贏行業」評級,考慮板塊估值中樞上移及公司業務逐月恢復,上調目標價8.8%至62元,對應預測今明兩年市盈率分別48.9倍及36.2倍。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account